Submitted by Anonymous (not verified) on 10 June 2025 - 16:25
Opinion/decision on a Paediatric investigation plan (PIP): Inaqovi, cedazuridine,decitabine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: P/0124/2024
Source: